Francesco Aiello

Rome, 00133, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications

Surgical Management of Corneal Damage in Patients with Primary and Post-Surgical Eyelid Anomalies.

Surgical Management of Corneal Damage in Patients with Primary and Post-Surgical Eyelid Anomalies.

Journal: Journal of clinical medicine
Published: March 18, 2026

A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.

A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases.

Journal: Ophthalmology and therapy
Published: March 16, 2026

Effects of Trehalose, Sodium Hyaluronate and N-Acetyl Aspartyl-Glutamic Acid Artificial Tears on Ocular Surface Parameters in Glaucoma Patients Receiving Preserved and Preservative-Free Prostaglandins.

Effects of Trehalose, Sodium Hyaluronate and N-Acetyl Aspartyl-Glutamic Acid Artificial Tears on Ocular Surface Parameters in Glaucoma Patients Receiving Preserved and Preservative-Free Prostaglandins.

Journal: Journal of clinical medicine
Published: March 10, 2026

Comparative Outcomes From 969 Endothelial Keratoplasties.

Comparative Outcomes From 969 Endothelial Keratoplasties.

Journal: Cornea
Published: January 22, 2026

Melatonin and glaucoma: Current insights and clinical prospectives.

Melatonin and glaucoma: Current insights and clinical prospectives.

Journal: Archivos de la Sociedad Espanola de Oftalmologia
Published: January 19, 2026

Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study.

Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study.

Journal: Frontiers in pharmacology
Published: January 04, 2026

Letter Regarding: "Quantitative Analysis of Endothelial Cell Damage in Corneal Grafts Used for Endothelial Keratoplasty and Correlation to Donor Tissue Characteristics and Postoperative Parameters".

Letter Regarding: "Quantitative Analysis of Endothelial Cell Damage in Corneal Grafts Used for Endothelial Keratoplasty and Correlation to Donor Tissue Characteristics and Postoperative Parameters".

Journal: Cornea
Published: December 31, 2025

Ocular injuries in padel: findings from a survey on frequency, risk factors, and perceptions toward protective eyewear.

Ocular injuries in padel: findings from a survey on frequency, risk factors, and perceptions toward protective eyewear.

Journal: Eye (London, England)
Published: October 28, 2025

Next-Gen Neuroprotection in Glaucoma: Synergistic Molecules for Targeted Therapy.

Next-Gen Neuroprotection in Glaucoma: Synergistic Molecules for Targeted Therapy.

Journal: Journal of clinical medicine
Published: July 21, 2025

Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis.

Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis.

Journal: Ophthalmology
Published: July 13, 2025

Topical WIN 55 212-2 Confers Long-Term Intraocular Pressure-Independent Neuroprotection in the DBA/2J Mouse Model of Glaucoma.

Topical WIN 55 212-2 Confers Long-Term Intraocular Pressure-Independent Neuroprotection in the DBA/2J Mouse Model of Glaucoma.

Journal: Ophthalmology science
Published: June 22, 2025

Flieringa scleral fixation ring-assisted Descemet membrane endothelial keratoplasty in complex eyes.

Flieringa scleral fixation ring-assisted Descemet membrane endothelial keratoplasty in complex eyes.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: May 17, 2025
Showing 1-12 of 82

Last Updated: 09/26/2026